2m 2m 2m 2m 2m 2m 2m
MAZE THERA (MAZE)
NASDAQ
$31.97-$0.61 (-1.87%)
Price as of Oct 22, 2026 7:50 PM EDT- $1.8BMarket Cap
- 11.88%1-Year Change
- BiotechnologyIndustry
MAZE THERA (MAZE)
$31.97-$0.61 (-1.87%)
MAZE | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $32.58 | ||
Change | +$0.13 (+0.40%) | ||
Open | $32.52 | ||
High | $33.19 | ||
Low | $31.55 | ||
Previous Close | $32.45 | ||
Volume | 1,068,351 | ||
30-Day Average Volume | 1,007,778 | ||
1-Week Change | 24.21% | ||
1-Month Change | 45.51% | ||
1-Year Change | 11.88% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 55.5M | ||
Total Assets | $531.6M | ||
Market Cap | $1.8B | ||
Enterprise Value | $1.6B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$44.7M | ||
Free Cash Flow | -$15.2M | ||
EBIT | -$43.8M | ||
EBITDA | -$43.4M | ||
Net Working Capital | $397.5M | ||
EPS | -$0.76 | ||
Enterprise Value/EBITDA | -38 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -43 | ||
PEG | 1 | ||
Price/Free Cash Flow | -119 | ||
Price/Operating Cash Flow | -120 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue